| 摘要 |
<p>Provided are methods and compositions for the modulation of hepatocyte growth factor activity to regulate lymphatic vessel development and function. Methods and composition for the monitoring and treatment of skin disorders, lymphedema, and metastatic cancers are disclosed. Also described are methods for identifying inhibitors of hepatocyte growth factor dependent lymphangiogenesis.</p> |
